Multiomic Health

Health Care · Precision Medicine
Lately:7 news stories in 90 daysFollow changes →

Facts

as of Nov 17, 2026

ABOUT.. MultiOmic Health has built a platform for discovering and developing life-changing precision medicines for age-related chronic multifactorial diseases where genetics alone cannot explain why numerous patients continue to progress despite being treated on standard of care.

Legal name
Multiomic Health Limitedactive
Headquarters
London, United Kingdom
Founded
2021
Employees
11-50estimated range
Register numbers
CRN 13246608
Official records
Companies House 13246608
Website
multiomic.health

These are the key facts about Multiomic Health on Alion as of Nov 17, 2026. Multiomic Health is headquartered in London, United Kingdom. It was founded in 2021. The latest round is Seed of $6.2M, announced in 2023.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Multiomic Health Limited
Yes
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
London United KingdomHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$6.2MTotal raised
$637kPublic grants1 public grant
Venture - Series UnknownLatest round
7Rounds and grants
Money by yearUSD, rounds and grants
2026-1 record
2025-1 record
2023$6.8M3 records
2022-1 record
2021-1 record
Largest rounds and grants
2023
$6.2M
2023
$637k
Sources: funding announcements, grant and company registers

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

Sep 232026
Blog
PRIVACY NOTICE & COOKIE POLICY who we are MultiOmic Health Limited, a private limited company registered in England and Wales (CRN: 13246608). Our registered office is located at…
Sep 232026
Blog
We are excited to announce our feature in the most recent edition of Nature Portfolio's Biopharma Dealmakers discussing the advances in AI-driven drug development.
Sep 232026
Blog
An Expert View from Henrietta Bull, science and partnership analyst, and Robert Thong, chief executive, MultiOmic Health.
Sep 232026
Blog
In this article, we look at how Mesh Bio and MultiOmic Health use AI to transform and improve the lives of metabolic syndrome patients through patient stratification and precisio…
Sep 232026
Blog
MultiOmic Health and Mesh Bio announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease.
Sep 232026
Podcast
In this week's episode of The Pharma Letter Podcast, MultiOmic chief executive Robert Thong discusses his firm's progress and ambitions for the future.
Sources: the outlets named on each headline, each story once